205 related articles for article (PubMed ID: 27767008)
1. Immune Responses to Invasive Group B Streptococcal Disease in Adults.
Edwards MS; Rench MA; Rinaudo CD; Fabbrini M; Tuscano G; Buffi G; Bartolini E; Bonacci S; Baker CJ; Margarit I
Emerg Infect Dis; 2016 Nov; 22(11):1877-1883. PubMed ID: 27767008
[TBL] [Abstract][Full Text] [Related]
2. The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera.
Fabbrini M; Rigat F; Rinaudo CD; Passalaqua I; Khacheh S; Creti R; Baldassarri L; Carboni F; Anderloni G; Rosini R; Maione D; Grandi G; Telford JL; Margarit I
Clin Infect Dis; 2016 Sep; 63(6):746-753. PubMed ID: 27402816
[TBL] [Abstract][Full Text] [Related]
3. Antibody responses in invasive group B streptococcal infection in adults.
Wessels MR; Kasper DL; Johnson KD; Harrison LH
J Infect Dis; 1998 Aug; 178(2):569-72. PubMed ID: 9697746
[TBL] [Abstract][Full Text] [Related]
4. Group B streptococcal colonization and serotype-specific immunity in healthy elderly persons.
Edwards MS; Rench MA; Palazzi DL; Baker CJ
Clin Infect Dis; 2005 Feb; 40(3):352-7. PubMed ID: 15668856
[TBL] [Abstract][Full Text] [Related]
5. Novel Multiplex Immunoassays for Quantification of IgG against Group B
Buffi G; Galletti B; Stella M; Proietti D; Balducci E; Romano MR; Mori E; Fabbrini M; Giuliani MM; Berti F; Margarit I
mSphere; 2019 Aug; 4(4):. PubMed ID: 31391276
[TBL] [Abstract][Full Text] [Related]
6. Natural acquired group B Streptococcus capsular polysaccharide and surface protein antibodies in HIV-infected and HIV-uninfected children.
Dzanibe S; Adrian PV; Kimaro Mlacha SZ; Madhi SA
Vaccine; 2016 Oct; 34(44):5217-5224. PubMed ID: 27663669
[TBL] [Abstract][Full Text] [Related]
7. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
Kasper DL; Paoletti LC; Wessels MR; Guttormsen HK; Carey VJ; Jennings HJ; Baker CJ
J Clin Invest; 1996 Nov; 98(10):2308-14. PubMed ID: 8941648
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate.
Davies HD; Adair C; McGeer A; Ma D; Robertson S; Mucenski M; Kowalsky L; Tyrell G; Baker CJ
J Infect Dis; 2001 Aug; 184(3):285-91. PubMed ID: 11443553
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib.
Baker CJ; Paoletti LC; Wessels MR; Guttormsen HK; Rench MA; Hickman ME; Kasper DL
J Infect Dis; 1999 Jan; 179(1):142-50. PubMed ID: 9841833
[TBL] [Abstract][Full Text] [Related]
10. Microbiological and clinical characteristics of Group B Streptococcus isolates causing materno-neonatal infections: high prevalence of CC17/PI-1 and PI-2b sublineage in neonatal infections.
Lu B; Wu J; Chen X; Gao C; Yang J; Li Y; Wang J; Zeng J; Fang Y; Wang D; Cui Y; Wang L
J Med Microbiol; 2018 Nov; 67(11):1551-1559. PubMed ID: 30265233
[TBL] [Abstract][Full Text] [Related]
11. Molecular epidemiology of group B streptococci in Ireland reveals a diverse population with evidence of capsular switching.
Meehan M; Cunney R; Cafferkey M
Eur J Clin Microbiol Infect Dis; 2014 Jul; 33(7):1155-62. PubMed ID: 24469423
[TBL] [Abstract][Full Text] [Related]
12. Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women.
Baker CJ; Paoletti LC; Rench MA; Guttormsen HK; Carey VJ; Hickman ME; Kasper DL
J Infect Dis; 2000 Oct; 182(4):1129-38. PubMed ID: 10979909
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of Invasive Group B Streptococcal Disease in Alberta, Canada, from 2003 to 2013.
Alhhazmi A; Hurteau D; Tyrrell GJ
J Clin Microbiol; 2016 Jul; 54(7):1774-1781. PubMed ID: 27098960
[TBL] [Abstract][Full Text] [Related]
14. Natural acquired humoral immunity against serotype-specific group B Streptococcus rectovaginal colonization acquisition in pregnant women.
Kwatra G; Adrian PV; Shiri T; Buchmann EJ; Cutland CL; Madhi SA
Clin Microbiol Infect; 2015 Jun; 21(6):568.e13-21. PubMed ID: 25680313
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III.
Baker CJ; Rench MA; Fernandez M; Paoletti LC; Kasper DL; Edwards MS
J Infect Dis; 2003 Jul; 188(1):66-73. PubMed ID: 12825173
[TBL] [Abstract][Full Text] [Related]
16. Maternal group B streptococcal immunization: capsular polysaccharide (CPS)-based vaccines and their implications on prevention.
Palmeiro JK; De Carvalho NS; Botelho AC; Fracalanzza SE; Madeira HM; Dalla-Costa LM
Vaccine; 2011 May; 29(21):3729-30. PubMed ID: 21414381
[TBL] [Abstract][Full Text] [Related]
17. Use of type V group B streptococcal conjugate vaccine in adults 65-85 years old.
Palazzi DL; Rench MA; Edwards MS; Baker CJ
J Infect Dis; 2004 Aug; 190(3):558-64. PubMed ID: 15243932
[TBL] [Abstract][Full Text] [Related]
18. Cervical secretions in pregnant women colonized rectally with group B streptococci have high levels of antibodies to serotype III polysaccharide capsular antigen and protein R.
Hordnes K; Tynning T; Kvam AI; Bevanger L; Brown TA; Jonsson R; Haneberg B
Scand J Immunol; 1998 Feb; 47(2):179-88. PubMed ID: 9496695
[TBL] [Abstract][Full Text] [Related]
19. Capsular switching in group B Streptococcus CC17 hypervirulent clone: a future challenge for polysaccharide vaccine development.
Bellais S; Six A; Fouet A; Longo M; Dmytruk N; Glaser P; Trieu-Cuot P; Poyart C
J Infect Dis; 2012 Dec; 206(11):1745-52. PubMed ID: 23002446
[TBL] [Abstract][Full Text] [Related]
20. Molecular characteristics and antimicrobial resistance in invasive and noninvasive Group B Streptococcus between 2008 and 2015 in China.
Lu B; Chen X; Wang J; Wang D; Zeng J; Li Y; Li D; Zhu F; Cui Y; Huang L
Diagn Microbiol Infect Dis; 2016 Dec; 86(4):351-357. PubMed ID: 27692802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
